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Abstract
Background: People seek treatment for malaria from a wide range of providers ranging from
itinerant drug sellers to hospitals. However, there are lots of problems with treatment provision.
Hence, factors influencing treatment provision in hospitals and non-hospitals require further
investigation in order to remedy the situation.
Objectives: To examine the knowledge, pattern of treatment provision and factors influencing the
behaviour of hospitals and non-hospitals in the treatment of malaria, so as to identify loci for
interventions to improve treatment of the disease.
Methods: A pre-tested structured questionnaire was used to collect data from 225 providers
from hospitals and non-hospitals about their malaria treatment practices and factors that influence
their provision of malaria treatment services in south-east Nigeria. The data from hospitals and
other providers were compared for systematic differences.
Results: 73.5% of hospitals used microscopy to diagnose malaria and only 34.5.1% of non-hospitals
did (p < 0.05). Majority of the respondents considered ability to pay bills (35.2%), already existing
relationship (9.4%) and body mechanism (35.2%) of the patient before they provided malaria
treatment services. Pressure from wholesalers to providers to repay the cost of supplied drugs was
the major influence of the type of drugs provided to patients.
Conclusion: There are many challenges to appropriate provision of malaria treatment services,
although challenges are less in hospitals compared to other types of non-hospitals. Improving
proper diagnosis of malaria and improving the knowledge of providers about malaria are
interventions that could be used to improve malaria treatment provision.
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Background
Malaria is the major cause of morbidity and mortality in
Nigeria, and particularly affects children under five years
of age [1]. Worldwide, it kills more than one million peo-
ple each year and between 20 and 40 percent of outpatient
visits and between 10 and 15 percent of hospital admis-
sions in Africa are attributed to malaria [2-4]. However,
the prevailing method for diagnosing malaria in SSA is by
clinical impression, which, in turn, typically amounts to
treating all fevers as malaria [5]. Hence, there is a potential
bias for overestimating the burden of the disease.
People seek treatment for malaria from a wide range of
sources ranging from itinerant drug sellers to hospitals,
but they often resort to the unregulated private commer-
cial sector, where treatment may be inappropriate,
although access costs may be lower [6]. Recourse to mul-
tiple providers is also common, and patients often begin
with self-treatment using drugs purchased through the
commercial sector, and then seek care from formal health
providers [6,7]. If a patient is very ill, the public sector
may be preferred because of the presence of more sophis-
ticated equipment and a greater range of staff [8]. Patients
may feel that private providers charge very high prices and
are often skeptical about the motivation of private provid-
ers, believing them to be primarily interested in generat-
ing income for themselves rather than in the welfare of
their patients [6,7,9].
However, there are many problems with treatment provi-
sion and existing practices, as well as factors influencing
treatment provision require further investigation in order
to remedy the situation. Over the years of deployment of
anti-malarial drugs, there was little incentive to improve
the way the drugs were used because chloroquine and sul-
phadoxine-pyrimethamine (SP) were inexpensive making
it more cost-effective to treat presumptively rather than to
get microscopic confirmation [5]. A previous study based
on an audit of 665 patient records from public and private
hospitals found that 45% of patients had diagnostic
blood slides, 77% were prescribed monotherapies and
only 3% were prescribed artemisin-based combination
therapy (ACT) [10]. It has also been found for private
shops that a large percentage of the drugs provided or dos-
ages given, or both, are inappropriate, indicating the need
for innovative and effective approaches to achieve rational
prescribing practices [11].
There is paucity of knowledge about the level of knowl-
edge of different providers about malaria, which will have
strong influences on their malaria treatment practices.
However, some researchers found that primary healthcare
providers had poor knowledge about prevention strate-
gies for malaria [12], and also that amongst primary
healthcare providers, knowledge of some basic concepts
of malaria was fairly adequate but treatment practices
were poor [13]. Hence they recommended that there
should be periodic education programmes, especially for
health workers with many years of experience to help
them maintain clinical skills and refresh their knowledge
[13]. In a study, to determine patent medicine dealers'
perspectives on malaria in south-east Nigeria, it was found
that although the providers had fairly good knowledge
about the causes and treatment of malaria, their treatment
provision practices were sub-optimal [2]. However, some
providers stated that malaria could be caused by the sun
and drinking bad water [2]
There is also paucity of knowledge about the factors that
influence the type of treatment that healthcare providers
provide for the treatment of malaria and how the infor-
mation can be used to improve treatment provision. The
behaviour of providers is often influenced by their knowl-
edge, financial incentives, competition, their perceptions
of patients' attitudes, and any legal or regulatory sanctions
for inappropriate behaviour [6]. It was also postulated
that prescribing patterns are more likely to follow patient
demands and expectations as well as profit motive rather
than professional principles [2]. However, previous stud-
ies have reported that clinicians rarely perceived patient
demand for anti-malarials and asserted that such demand
for medication would not affect their prescribing behav-
iour [14].
It is rationally expected that provision of anti-malarial
drugs would be rational in hospitals compared to other
providers such as retailers like patent medicine dealers
(PMDs) and other low level providers that may not have
properly trained health personnel such as doctors. Inap-
propriate provision of drugs can lead to many untoward
effects and decrease the effectiveness of treatment, as well
as lead to poor adherence [10,15]. Some researchers
found a wide variety of anti-malaria drug prescribing
including chloroquine, SP and ACT, but with overall pre-
scribing in government and private facilities being similar
[10]. Few retailers understood their role in the delivery of
primary health care for instance about 80.0% of the non-
pharmacist - retailers considered themselves as traders
rather than as healthcare providers [16]. Polypharmacy,
where providers prescribe additional unnecessary drugs, is
widespread [6,17]. In recent times, four primarily social,
spheres of influence on malaria over-diagnosis were iden-
tified: firstly, the influence of initial training within a con-
text where the importance of malaria is strongly
promoted. Secondly, the influence of peers, conforming
to perceived expectations from colleagues. Thirdly, pres-
sure to conform with perceived patient preferences. Lastly,
quality of diagnostic support, involving resource manage-
ment, motivation and supervision [18].Malaria Journal 2009, 8:246 http://www.malariajournal.com/content/8/1/246
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The paper explores the reasonable uncharted ground of
comparing hospitals with non-hospitals based on the
premise that public and private hospitals are basically
similar in terms of type of people that actually provide
services there as well as in terms of malaria treatment prac-
tices. The paper does not tread the usual comparison of
public versus private providers because the private sector
is very heterogenous ranging from itinerant drug sellers,
patent medicine dealers to private teaching hospitals.
Also, the public sector is also heterogenous ranging from
dispensaries, primary healthcare (PHC) clinics, health
posts, PHC centres, comprehensive health centres and
hospitals. Hence, many a times, it is not clear the aspect of
the private sector and the public sector that are been com-
pared. Therefore, a worthwhile comparison for program-
matic purposes is investigating what happens in hospitals
versus non-hospitals. Hence, the paper provides informa-
tion about the characteristics and determinants of provi-
sion of malaria treatment by hospitals and non-hospitals,
factors that influence provision of malaria treatment serv-
ices and potential areas for intervention to improve
malaria treatment provision.
Methods
Study area
The study was undertaken in Anambra state, southeast
Nigeria. This part of the country is one of the most impor-
tant sources of anti-malaria drugs in Africa and the
"Bridge-Head" market in Onitsha, Anambra State is at the
centre of this trade. Anambra state has a high malaria
transmission rate all year and the annual incidence rate is
10 to 35%. Six sites were chosen for the study. These were
the three largest urban centres (Awka- state capital, Nnewi
and Onitsha). One rural LGA was randomly selected from
each senatorial zones in the state (Njikoka, Aguata and
Ogbaru). Then, one community from each of the three
rural LGAs: Enugwu-Ukwu (Njikoka LGA), Ekwulobia
(Aguata LGA) and Okpoko (Ogbaru LGA) was selected
using two-stage sampling. Each site area has a full comple-
ment of providers from hospitals to itinerant drug provid-
ers and herbalists.
Data collection
It was a cross-sectional study using pre-tested structured
questionnaires to collect information from a broad spec-
trum of healthcare providers by trained interviewers. The
questionnaire was administered to the heads or owners of
selected public and private providers/outlets. The
employee running the facilities/outlets was interviewed in
the absence of the owner/head. Data were collected on the
level of providers' knowledge regarding malaria, provi-
sion of malaria treatment services (diagnosis, treatment
and follow-up), and influences on provider behaviour.
Sampling and sampling method
The sample size was determined by considerations of the
range of providers and feasibility. A total of 50 providers
(public and private) in each urban and 25 in each rural
area were selected. The breakdown among private provid-
ers was determined on the basis of their utilization rate by
consumers, using existing data [19]. All the existing public
providers in each study area were included in the study,
because there are not many of them. Two-stage sampling
was used to select the providers so that all categories of
public and private providers were well represented in the
study. The sampling frame were providers that use ortho-
dox drugs to treat patients and they included all levels of
care in public facilities and the broad spectrum of private
providers ranging from hospitals, clinics, pharmacy
shops, patent medicine dealers and mixed goods dispens-
ers. A listing of all providers was undertaken using the
membership registers of their professional associations or
trade unions. A "snowball" approach was used to update
these initial lists, by asking registered providers to furnish
names and locations of others that are not in the registers
of their respective associations.
Data collected
Data was collected on the level of education of providers',
their knowledge regarding malaria, their perceptions and
practices of provision of malaria treatment services (diag-
nosis, treatment and follow-up), and influences on pro-
vider behaviour.
Data analysis
The data was analysed for aggregated data from hospitals
and non-hospitals using SPSS and EpiInfo software pack-
ages. The main influences on provider behaviour were
evaluated through quantitative analysis of the provider
questionnaire responses. Chi-square tests were used to
compare the elicited data between hospitals and non-hos-
pitals.
Results
General characteristics of the providers
A total of 137 PMDs, four mixed goods sellers, 22 PHC
centres, six maternity homes, 20 private hospitals, three
other low level providers, such as community-health
workers and itinerant drug sellers, eight laboratories, 11
pharmacy shops, 11 public hospitals and three other types
of hospitals were interviewed. Thus, there were 34 hospi-
tals and 191 Non-hospitals. Amongst, the non-hospitals,
those in maternity homes had the highest average number
of years of formal training for the work that they do,
whilst providers in 'others' category had the highest
number of formal education. Similarly, it was providers in
'other healthcare facilities' that had the highest number of
years of training for the work that they do, whilst provid-Malaria Journal 2009, 8:246 http://www.malariajournal.com/content/8/1/246
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ers in private hospitals, the general hospitals had the high-
est level of education for medium/high level providers.
Knowledge of the providers about causes, symptoms, 
diagnosis and treatment of malaria
The three most important illnesses that the providers' cli-
ents had were malaria (91.4%), diarrhoea (39.8%) and
typhoid fever (32.0%). Most of the providers correctly
identified mosquitoes as the cause of malaria and the dif-
ference between providers in hospitals and non-hospitals
was no statistically significant (Table 1). However, there
were more instances of erroneous identification of main
causes of malaria by providers in non-hospitals compared
to hospitals, where drinking impure water, lack of envi-
ronmental sanitation and exposure to sunlight were iden-
tified as causes of malaria.
Comparatively, all (100%) providers in hospitals and just
87.4% of non-hospitals stated that malaria was a serious
health problem (p < 0.05). The main method that the pro-
viders stated that could be used to diagnose malaria was
through recognition of symptoms (85.2%). Microscopic
examination of blood slides was stated by only 27.3% of
the providers. All the providers equally recognized all the
symptoms of malaria, with the exception of headache,
which was recognized less by hospitals and vomiting,
which was recognized more by hospitals (Table 2). Sur-
prisingly, convulsion and anaemia were the least recog-
nized symptoms of malaria by both hospitals and Non-
hospitals, although there was far greater recognition of
anaemia in hospitals compared to non-hospitals (p <
0.05).
Most of the providers; 88.2% and 87.4% in hospitals and
non-hospitals respectively stated that recognition of
symptoms could be used to tell that someone has malaria.
However, whilst 58.8% of providers in hospitals stated
that microscopy could be used to diagnose malaria, only
30.4% of providers in non-hospitals had a similar opin-
ion (p < 0.05). Only 2 (5.9%) of hospitals and no non-
hospital stated that rapid diagnostic tests (RDTs) could be
used to diagnose malaria (p < 0.05). 58.8% of the hospi-
tals had functional microscopes, reagents and slides for
microscopy. Conversely, only 15.7%, 14.7% and 14.7%
of non-hospitals had functional microscopes, reagents
and slides. The differences between hospitals and non-
hospitals were statistically significant (p < 0.05).
Practices of the providers
Table 3 shows that in actual practise, malaria diagnosis
was based mostly on recognition of symptoms by 82.4%
of hospitals and 87.4% of non-hospitals. However, whilst
73.5% of hospitals used microscopy to diagnose malaria,
only 34.5.1% of non-hospitals did (p < 0.05). Also, only
5.9% and 0% of hospitals and non-hospitals used RDT (p
< 0.05). Incidence of patients using self recognition of
symptoms to ask for treatment was found mostly in non-
hospitals.
82.4% of hospitals and 66.7% of non-hospitals stated that
taking medicines was the best way to cure malaria (Table
4). However, 1%, 24%, 5.8% and 0.5% of non-hospitals
stated that no treatment, changing the diet, cleaning the
environment and religious healing could be used to cure
malaria.
The drugs that all providers stocked for the treatment of
malaria included artesunate monotherapy, chloroquine
(CQ) tablets, CQ injections, antibiotics, SP, quinine, ACT,
herbal preparations, halofantrine and others. Chloro-
quine and SP were the most common medications that
the providers give to their patients. Comparatively, whilst
44.1% of hospitals provided artesunate monotherapy, it
was 31.4% for non-hospitals. Also, 11.2% of hospitals
and 7.9% of non-hospitals provided ACT to their patients.
Quinine was provided by 41.2% of hospitals and 23% of
non-hospitals (p < 0.05). Herbal treatment was also pro-
vided by 5.9% of hospitals and 1% of non-hospitals.
Table 5 shows that less stock-outs of drugs occurred in
hospitals compared to non-hospitals (p < 0.05). Tablets
followed by injections were the most common anti-
malarials drug formulations provided. Table 6 shows that
hospitals tended to give more injections and intravenous
infusions to patients compared to non-hospitals (p <
0.05).
Factors influencing malaria treatment provision: motives 
and incentives for service provision
Majority of the providers considered ability to pay bills
(35.2%), already existing relationship (9.4%) and body
Table 1: Main causes of malaria
Non-hospitals
n (%)
N = 191
Hospitals
n (%)
N = 34
Chi-square(p-value)
Mosquitoes 176 (92.5%) 33 (97) 1.7 (.17)
Lack of sanitation 106 (55.4%) 9 (26.5) 9.1 (.003)
Drinking impure water 32 (16.7%) 2 (5.88) 2.5 (.08)
Exposure to sunlight 15 (7.8%) 0 (0) 2.8 (.08)
Others 42 (21.9) 3 (8.8) 3.0 (.06)Malaria Journal 2009, 8:246 http://www.malariajournal.com/content/8/1/246
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mechanism - cursory ill-health appearance of the patient -
(35.2%) of the patient before they provided specific
malaria treatment services to the patients. There were no
statistical significant differences in consideration of ability
to pay bills and already existing customer relationship
between hospitals and Non-hospitals. However, 37.2% of
non-hospitals and 58.8% of hospitals considered body
mechanisms (how the patients visually looks - weak, col-
lapsing or otherwise) before commencing treatment (p <
0.05).
Table 7 shows that pressures from wholesalers to provid-
ers to repay the cost of supplied drugs was the major influ-
ence of the type of drugs provided to patients and there
was no statistically significant differences between hospi-
tals and non-hospitals. Request by patients was the next
commonest factor influencing treatment but it was more
evident in non-hospitals compared to hospitals (p <
0.05). Also, respondents said that request by the patients,
patient's apparent socio-economic status (SES), their idea
of what the patients want and drugs available were the
major determinants of the amount of money they charge
for an episode of malaria. The necessity to make a profit
was a more important factor in Non-hospitals compared
to hospitals (p < 0.05). Other determinants were level of
training of providers, necessity to make profit, need to be
competitive, drugs available and existing treatment pol-
icy/guidelines. There was no statistical significant differ-
ence in factors influencing the amount of money charged
for treatment between hospitals and non-hospitals.
Discussion
The level of knowledge about malaria by all the providers
was good, although it was worrisome to find out that
some providers had the wrong notion about the cause of
the diseases and many providers failed to recognize that
convulsion and anemia were symptoms of malaria. Some
other researchers also found in their study of PMDs, that
although the respondents were well informed about
causes and symptoms of malaria, there were some mis-
conceptions about the causes of malaria, incriminating
the hot sun and drinking bad water [2]. The finding that
convulsion was not stated as a symptom of malaria by
many of the providers has serious implications for treat-
ment of the disease as many people will not be treated if
convulsion is the presentation [2]. However, it was
observed that most of the providers stated that malaria
was a very serious illness [2].
Laboratory diagnosis can improve rational provision of
malaria treatment services, but the results show that only
few providers, including hospitals, actually use any labo-
ratory diagnosis. The finding of low use of microscopy for
diagnosis in the study differs from the findings of a previ-
Table 2: Symptoms of malaria
Non-hospitals
n (%)
N = 191
Hospitals
n (%)
N = 34
Chi-square (p-value)
Fever 173 (90.5%) 33 (97%) 2.2 (.23)
Shivering 63 (33.0%) 15 (44.1%) 1.8 (.24)
Convulsion 9 (4.7%) 3 (8.8%) 1.0 (.39)
Headache 176 (92.5%) 26 (76.5%) 5.3 (.028)
Anaemia 5 (2.6%) 16 (47.1%) 9.8 (.002)
Vomiting 79 (41.4%) 20 (58.8%) 4.0 (.036)
Diarrhoea 11 (5.8%) 1 (3.0%) .43 (.44)
Loss of appetite 113 (59.2%) 19 (55.8%) .05 (.48)
Fatigue 81 (42.4%) 14 (41.2%) .002 (.56)
Others 127 (66.5%) 28 (82.4%) 3.9 (.033)
Table 3: How malaria is actually diagnosed
Non-hospitals
n (%)
N = 191
Hospitals
n (%)
N = 34
Chi-square (p-value)
Physical exam only 52 (27.2) 12 (35.9) 1.3 (.17)
Recognition of symptoms 167 (87.4) 28 (82.4) 0.14 (.54)
Microscopy 66 (34.5) 25 (73.5) 20.5 (.0001)
Dipstick (RDT) 0 (0) 2 (5.9) 11.9 (.020)
Sufferer recognize & asks for treatment 21 (11.0) 7 (20.6) 2.9 (.085)
Others 21 (11.0) 4 (11.8) .053 (.51)Malaria Journal 2009, 8:246 http://www.malariajournal.com/content/8/1/246
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ous study where there was a high level of use of micros-
copy [10]. The disparity could be because the other study
[10] was based on audit of patients' records from hospi-
tals, whilst the present study was based on data collected
from all levels of healthcare providers. Syndromic diagno-
sis (presumptive treatment) of malaria results in unneces-
sary prescribing of anti-malarials [20]. It was found that
prescribing anti-malarials only after laboratory confirma-
tion reduced the total number of prescriptions by 68% in
Malawi [20].
There was apparent irrational provision of anti-malarial
drugs in the study and it was interesting to find out that
providers stocked the full range of anti-malarials includ-
ing the failing ones and that some provided antibiotics to
their patients as part of malaria treatment. Whilst this may
be rational drug provision of antibiotics in some
instances, it may be irrational in other cases if the drugs
are not properly provided in correct type, dosage and indi-
cation. Antibiotics are overused in both rural and urban
settings of a district in Tanzania and this was due to both
clinician's and drug sellers' prescribing practices in public
and private facilities [21]. In many situations, practices
that could be best described as misuse of drugs have
become routine, and in many cases, institutionalized and
promoted [5]. An example is syndromic diagnosis that
was widespread in the study area. As was found in this
study and other studies [22], injection use is often unnec-
essary. Similarly it was found that prescribing for adult
malaria by many providers did not conform to the treat-
ment guidelines [23].
Many interesting factors that were found to influence pro-
viders' malaria treatment provision behaviour are point-
ers to how such a behaviour could be modulated to
improve the treatment of malaria. The finding that patient
demand was a significant factor that affected treatment
provision of non-hospitals, but not of hospitals, supports
the results of earlier studies that found that prescribing
patterns are more likely to follow patient demands for
patent medicine dealers [2], but that patient demand for
anti-malarials would not affect the prescribing behaviour
of clinicians in hospitals[14]. The finding that patients'
body mechanism on presentation to the providers was a
strong determining influence for the commencement of
treatment especially in hospitals was not unexpected
given that training of doctors and other providers usually
found in hospitals emphasize the use of triage in deciding
on who and when to start treatment especially in emer-
gencies. The result showed that hospitals were very likely
to commence immediate treatment if they notice appar-
ently very ill patients and may not start treatment of the
patient does not appear quite ill. It will be important to
educate all providers that the body mechanism of clients
though important should not overtly outweigh other con-
siderations for starting treatment as some people espe-
Table 4: Best ways to cure malaria
Non-hospitals
n (%)
Hospitals
N (%)
Chi-square (p-value)
No treatment 2 (1.0) 0 (0) .34 (.73)
Medicine 126 (66.7) 28 (82.4) 5.27 (.015)
Change diet 46 (24.0) 0 (0) 9.8 (.0001)
Clean house, environment or body 11 (5.8) 0 (0) 2.0 (.17)
Religious healing 1 (0.5) 0 (0) .17 (.86)
Herbal medicines 0 (0) 0 (0) NA
Others 53 (27.7) 13 (38.2) 2.1 (.11)
Table 5: Level of stock-outs of anti-malarial drugs in the past one month
Non-hospitals
N = 191
Hospitals
N = 34
Chi-square (p-value)
Yes
n (%)
Don't normally stock
n (%)
Yes
n (%)
Don't normally stock
n (%)
AMT 17 18 2 13 23.0 (.0001)
CQ 111 1 5 1 20.4 (.0001)
Antibiotics 16 5 4 3 4.6 (.10)
SP 97 11 3 6 21.0 (.0001)
Quinine 17 25 5 9 7.5 (.023)
Halofantrine 24 28 3 14 15.9 (.0001)
O t h e r s 4 6 55 11 . 0  ( . 6 0 )Malaria Journal 2009, 8:246 http://www.malariajournal.com/content/8/1/246
Page 7 of 8
(page number not for citation purposes)
cially children that may not look quite ill, could actually
be dying.
In this study, the finding that pressures from wholesalers
to the providers to repay the cost of drugs supplied to
them was a major determinant of the drugs provided is
worrisome. This is because, it could lead to a lot of sup-
plier-induced demand and provision of unnecessary
drugs thereby worsening the economic burden of the dis-
ease on the consumers and predisposing to development
of drug resistance if the drugs are wrongly used. However,
a study of patent medicine dealers in Nigeria showed that
customers' specific demand was the main determining
factor for the treatment provided [2]. A previous study
done to explore to what extent current prescribing behav-
iour is driven by patient demand in five district hospitals
found that patients were not observed to demand anti-
malarials from clinicians but occasionally asked for a
malaria slide and that clinicians rarely reported perceiving
patient demand for anti-malarials asserted that such
demand for medication would not affect their prescribing
behaviour [14].
Interventions at policy and programmatic levels should be
instituted so as to improve treatment provision. One obvi-
ous intervention will be ensuring that providers stocked
adequate doses of ACT and improving laboratory diagno-
sis especially as the expensive forms of ACT are now first-
line treatment of malaria, so as to decrease unnecessary
treatment and reduce societal costs of the disease. Inter-
ventions are also needed to decrease the use of injections
especially in hospitals, which is a common means of treat-
ment in Nigeria [2]. Other interventions would entail
behaviour change and communication to improve pro-
viders' behaviour. There have been suggestions that con-
tinuing education to prescribers and providers,
monitoring, supervision and public education could be
used to curb irrational drug prescribing [22]. It has been
acknowledged that although changing private sector prac-
tices is widely acknowledged to be slow and difficult [24],
this change helps to improve their treatment provision
practices [25]. Previous studies have shown that vendor-
to-vendor education improved the treatment of malaria in
private outlets in Kenya, by improving their stocking pat-
terns, malaria knowledge and prescribing practices of
shops/kiosks, but not consistently on other types of out-
lets [24]. Similarly, training of providers, especially drug
sellers, has been shown to improve drug use in Kenya
[26].
Conclusion
Finally, there are many challenges to appropriate provi-
sion of malaria treatment services, although challenges
are less in hospitals compared to other types of healthcare
providers. Ensuring adequate supply of appropriate drugs,
using favourable drug supply terms that will not pressu-
Table 6: Types of drug formulations most commonly given to patients for malaria
Non-hospitals
n (%)
Hospitals
n (%)
Chi-square (p-value)
Injection 67 (35.0) 27 (79.4) 27.8 (.00001)
Tablets 177 (92.7) 30 (88.2) .16 (.51)
IV infusion 15 (7.9) 12 (35.3) 23.0 (.0001)
Suppositories 5 (2.6) 2 (5.9) 1.2 (.26)
Others 41 (21.5) 10 (29.4) 1.6 (.15)
Table 7: Factors influencing the type of drugs provided for patients
Non-hospitals
n (%)
N = 191
Hospitals
n (%)
N = 34
Chi-square (p-value)
Necessity to make profit 18 (9.4) 3 (8.8) .01 (.60)
Request by patients 76 (39.8) 5 (2.6) 6.7 (.006)
Idea of what the consumer prefers 17 (8.9) 5 (2.6) 1.5 (.19)
Patients apparent SES 37 (19.4) 10 (29.4) 2.4 (.096)
Providers' level of training 31 (16.2) 5 (2.6) .004 (.594)
Need to be competitive 5 (2.6) 0 (0) .85 (.46)
Drugs available 35 (18.3) 2 (5.9) 2.8 (.07)
Existing treatment policy/guidelines 26 (13.6) 1 (2.9) 2.7 (.07)
Information from regulatory bodies 10 (5.2) 0 (0) 1.7 (.21)
Pressures from wholesalers to repay 89 (46.6) 22 (64.7) .17 (.85)
Promotion by manufacturers 3 (1.6) 0 (0) .50 (.63)
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rize providers to indulge in supplier-induced demand or
over-prescription, limiting the influence of patients in
demanding specific treatment, improving proper diagno-
sis of malaria and improving the knowledge of providers
about malaria are interventions that could be used to
improve malaria treatment provision. However, the desire
to limit provision of anti-malarial drugs to those who
need them fails to account for the systematic realities that
limit the availability of accurate diagnosis to only a small
fraction of the population [5]. Hence in the interregnum
between widespread use of laboratory diagnosis whether
through microscopy or RDTs, the health system should
include strategies such as Integrated management for
childhood illnesses (IMCI), Integrated preventive treat-
ment for pregnant women (ITPp) and possibly Integrated
preventive treatment for infants (IPTi), to ensure that eve-
rybody that needs malaria treatment is properly treated,
without having to necessarily wait for laboratory confir-
mation of diagnosis.
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